- Page 1 and 2: Supplement to: VOL. 106 NO. 3S SEPT
- Page 3: The first six papers are candidates
- Page 7 and 8: MATERIALS AND METHODS: Letrozole/FS
- Page 9 and 10: expulsion rates were 3.7% for both
- Page 11 and 12: exposure continues to be a major pu
- Page 13 and 14: were no statistically significant d
- Page 15 and 16: References: 1. Br€annstr€om M,
- Page 17 and 18: O-38 Monday, October 17, 2016 11:30
- Page 19 and 20: the embryo was based solely upon th
- Page 21 and 22: ART: CLINICAL 1 O-49 Monday, Octobe
- Page 23 and 24: Odds of Term LBW According to Vario
- Page 25 and 26: ETof male vs. female embryos: patie
- Page 27 and 28: Differences in Outcomes between Day
- Page 29 and 30: eaching the blastocyst stage by Day
- Page 31 and 32: TIMING OF FERTILITY PRESERVATION Va
- Page 33 and 34: References: 1. McLaughlin T, Lamend
- Page 35 and 36: chromosomal status of embryos and,
- Page 37 and 38: OBJECTIVE: To longitudinally assess
- Page 39 and 40: clinical parameters as well as the
- Page 41 and 42: sought out medical tourism in the C
- Page 43 and 44: animals between 7 and 13 days and t
- Page 45 and 46: MALE REPRODUCTION AND UROLOGY: CLIN
- Page 47 and 48: O-114 Tuesday, October 18, 2016 12:
- Page 49 and 50: P on quantitative immunoblotting co
- Page 51 and 52: mated on day 28 post-BMT. In a sepa
- Page 53 and 54: decreased but DETs were predominant
- Page 55 and 56:
OBJECTIVE: To evaluate pregnancy an
- Page 57 and 58:
pregnancy, live birth rate and misc
- Page 59 and 60:
O-143 Tuesday, October 18, 2016 12:
- Page 61 and 62:
Day 3 ‘‘no result’’embryos
- Page 63 and 64:
financial support, mostly from fami
- Page 65 and 66:
G. D. Palermo. Reproductive Medicin
- Page 67 and 68:
O-164 Tuesday, October 18, 2016 11:
- Page 69 and 70:
OUTCOME PREDICTORS: ART 2 O-169 Tue
- Page 71 and 72:
and the X 2 test was used for categ
- Page 73 and 74:
Table 1. Fresh vs. elective FET in
- Page 75 and 76:
Table 1: SA Parameters and Cycle Ty
- Page 77 and 78:
(ANOVA) of the degree and distribut
- Page 79 and 80:
line stem cells referred to ovarian
- Page 81 and 82:
that patients with EGT have poor GU
- Page 83 and 84:
microvessel density (MVD) of breast
- Page 85 and 86:
step of culture significantly impro
- Page 87 and 88:
syndrome and other chromosome abnor
- Page 89 and 90:
ate while minimizing the multiple b
- Page 91 and 92:
CLINICAL REPRODUCTIVE LABORATORY O-
- Page 93 and 94:
14. Ombelet W, Vandeput H, Van de P
- Page 95 and 96:
Mean 12-month costs in 2014 $ (SD)
- Page 97 and 98:
(HMB) and tumor size. We report the
- Page 99 and 100:
RESULTS: Gross inspection of the tr
- Page 101 and 102:
RESULTS: A total of 39,643 cycles b
- Page 103 and 104:
stimulation (p
- Page 105 and 106:
eSET with 1 embryo frozen No. Live
- Page 107 and 108:
previously demonstrated, in our mou
- Page 109 and 110:
(25%). Fertilization and cleavage r
- Page 111 and 112:
MATERIALS AND METHODS: 197 men from
- Page 113 and 114:
to respond and offer support and re
- Page 115 and 116:
questionnaire. Baseline demographic
- Page 117 and 118:
DESIGN: Descriptive analysis of bas
- Page 119 and 120:
(IFU) accompanying the demonstratio
- Page 121 and 122:
(0.3, 2.9), and median (IQR) BW was
- Page 123 and 124:
Elecsys ¼ 2,650 ng/ml with 95% CI
- Page 125 and 126:
AFC, and NOR. Women were further ca
- Page 127 and 128:
which is believed to be due to the
- Page 129 and 130:
y blastomere or blastocyst sampling
- Page 131 and 132:
P-62 Tuesday, October 18, 2016 INFE
- Page 133 and 134:
Current State of OT with Cryopreser
- Page 135 and 136:
P-73 Tuesday, October 18, 2016 A NO
- Page 137 and 138:
efficiency and wider variation in p
- Page 139 and 140:
DESIGN: This ongoing retrospective
- Page 141 and 142:
maternal age, ovulation trigger dru
- Page 143 and 144:
Table 1. Fresh vs. Freeze-all in po
- Page 145 and 146:
P-101 Tuesday, October 18, 2016 THE
- Page 147 and 148:
vs 43%, 78/183, respectively). With
- Page 149 and 150:
P-110 Tuesday, October 18, 2016 COR
- Page 151 and 152:
P-116 Tuesday, October 18, 2016 EVO
- Page 153 and 154:
OBJECTIVE: To determine if embryo m
- Page 155 and 156:
3:3, 4:2, 5:1, and 6:0). A euploid
- Page 157 and 158:
aberration respectively; direct cyt
- Page 159 and 160:
RESULTS: 1,417 families were analyz
- Page 161 and 162:
CONCLUSIONS: This report details a
- Page 163 and 164:
DESIGN: Retrospective data analysis
- Page 165 and 166:
4. Vaccari, S., J. Conaghan, and P.
- Page 167 and 168:
P-161 Tuesday, October 18, 2016 TOT
- Page 169 and 170:
Risks of Adverse Outcomes Compared
- Page 171 and 172:
CONCLUSIONS: Even though all study
- Page 173 and 174:
P-178 Tuesday, October 18, 2016 ARE
- Page 175 and 176:
c Physician, Kiryat Ono, Israel; d
- Page 177 and 178:
DESIGN: This was a multicentre retr
- Page 179 and 180:
Live Birth Rates (LBR, %) and Multi
- Page 181 and 182:
on first-trimester ultrasound were
- Page 183 and 184:
Outcomes by number of blastocysts i
- Page 185 and 186:
P-209 Tuesday, October 18, 2016 OOC
- Page 187 and 188:
Demographic Characteristics and Lab
- Page 189 and 190:
numbers. We have also analyzed the
- Page 191 and 192:
Table 1: There is no difference in
- Page 193 and 194:
15 to 51 oocytes is -0.004 (95% CI
- Page 195 and 196:
AGE and improvement of pregnancy ra
- Page 197 and 198:
CONCLUSIONS: Despite similar embryo
- Page 199 and 200:
CONCLUSIONS: Despite prior speculat
- Page 201 and 202:
P-249 Tuesday, October 18, 2016 CLI
- Page 203 and 204:
P-254 Tuesday, October 18, 2016 DOE
- Page 205 and 206:
Live singleton births after fresh v
- Page 207 and 208:
Patients with a second STEET after
- Page 209 and 210:
Differences in Outcomes between Day
- Page 211 and 212:
to be higher too. This study shatte
- Page 213 and 214:
culture with 1000 nM E 2 . These re
- Page 215 and 216:
MATERIALS AND METHODS: Women with r
- Page 217 and 218:
flow; Group B (n¼394): with increa
- Page 219 and 220:
P-296 Tuesday, October 18, 2016 IDE
- Page 221 and 222:
in their isthmocele that was remove
- Page 223 and 224:
RESULTS: CE of RS-ost is summarized
- Page 225 and 226:
consecutive cases were made during
- Page 227 and 228:
OBJECTIVE: To evaluate reproductive
- Page 229 and 230:
A: 43 %1% (n¼101) // >4% (n¼235)
- Page 231 and 232:
of the patients. In the same period
- Page 233 and 234:
factor (group 1A, malesyears old),
- Page 235 and 236:
K. B. Bjugstad, e K. Khalafalla, f
- Page 237 and 238:
16% had unpaired XY. Only 25% of sp
- Page 239 and 240:
genomic hybridization (aCGH). Copy
- Page 241 and 242:
treatment parameters. Age and FSH a
- Page 243 and 244:
absorptiometry (DXA) allows for hig
- Page 245 and 246:
transfer of three or more morpholog
- Page 247 and 248:
OBJECTIVE: Recently high powered st
- Page 249 and 250:
circadian clock may be related with
- Page 251 and 252:
young adult female monkeys. Am J Ph
- Page 253 and 254:
of oligo-ovulation in some patients
- Page 255 and 256:
volume (OV) > 10cm 3 . The data to
- Page 257 and 258:
P-398 Wednesday, October 19, 2016 S
- Page 259 and 260:
and had a live birth in the last tw
- Page 261 and 262:
continued to the day of oocyte pick
- Page 263 and 264:
P-415 Wednesday, October 19, 2016 I
- Page 265 and 266:
P-421 Wednesday, October 19, 2016 H
- Page 267 and 268:
telomere length, telomere aggregate
- Page 269 and 270:
P-433 Wednesday, October 19, 2016 G
- Page 271 and 272:
DESIGN: This prospective single-cen
- Page 273 and 274:
of epithelial and stromal cells in
- Page 275 and 276:
P-448 Wednesday, October 19, 2016 E
- Page 277 and 278:
P-453 Wednesday, October 19, 2016 I
- Page 279 and 280:
assigned to their matched controls.
- Page 281 and 282:
activity. CCL25 promotes invasion o
- Page 283 and 284:
end of the 3-month treatment (n ¼
- Page 285 and 286:
the testis, and agglomerates of AgN
- Page 287 and 288:
is related to exponential increase
- Page 289 and 290:
are found only in the 20-hour group
- Page 291 and 292:
OBJECTIVE: The growing interest in
- Page 293 and 294:
Changes with LIVE Technique with Ti
- Page 295 and 296:
P-497 Wednesday, October 19, 2016 O
- Page 297 and 298:
MATERIALS AND METHODS: Healthy men
- Page 299 and 300:
DESIGN: Retrospective medical recor
- Page 301 and 302:
likely to have ever been employed b
- Page 303 and 304:
may be most apropos in patients wit
- Page 305 and 306:
pathologies. Unique findings of the
- Page 307 and 308:
RESULTS: Pregnancy rates (PR) and l
- Page 309 and 310:
Direct division from 1 to 3 cells e
- Page 311 and 312:
5. Spandorfer SD, Clarke R, Bovis L
- Page 313 and 314:
P-545 Wednesday, October 19, 2016 U
- Page 315 and 316:
Scion-Image software was used to me
- Page 317 and 318:
tween basal inhibin B levels and th
- Page 319 and 320:
measurements were retrospectively m
- Page 321 and 322:
ART - CLINICAL P-565 Wednesday, Oct
- Page 323 and 324:
Relative risk of donor cycle outcom
- Page 325 and 326:
RESULTS: We found that the noncompl
- Page 327 and 328:
the literature to identify characte
- Page 329 and 330:
RESULTS: There were 274 clinics wit
- Page 331 and 332:
Miscarriage rates were 16.9% 95%CI(
- Page 333 and 334:
syndrome: two distinct entities wit
- Page 335 and 336:
conflicting results in the current
- Page 337 and 338:
RESULTS: Average age of oocyte dono
- Page 339 and 340:
I. Kang, b T. K. Yoon, b H. Song. a
- Page 341 and 342:
Surprisingly, out of 32 cases, 19 (
- Page 343 and 344:
Reproductive Science, Icahn School
- Page 345 and 346:
Primary diagnosis GnRH antagonist c
- Page 347 and 348:
of infertility, indications for IVF
- Page 349 and 350:
P-640 Wednesday, October 19, 2016 A
- Page 351 and 352:
were made using Prism software. Stu
- Page 353 and 354:
CONCLUSIONS: Faster progression to
- Page 355 and 356:
using a time-lapse embryo monitorin
- Page 357 and 358:
drops may stress embryos and could
- Page 359 and 360:
trophectoderm biopsy and analyzed v
- Page 361 and 362:
abnormal and these zygotes should b
- Page 363 and 364:
P-678 Wednesday, October 19, 2016 G
- Page 365 and 366:
knocked-down TP53 in two WT hESC li
- Page 367 and 368:
Doctors should be able to help tran
- Page 369 and 370:
2004-2013 White Asian Black Hispani
- Page 371 and 372:
compared with the PGD group. Chromo
- Page 373 and 374:
P-705 Wednesday, October 19, 2016 G
- Page 375 and 376:
lastocysts), was calculated at 50%,
- Page 377 and 378:
MATERIALS AND METHODS: The patient
- Page 379 and 380:
AUTHOR INDEX Abbas, A., P-303, P-30
- Page 381 and 382:
Camargo, M., P-505 Camarillo, D. B.
- Page 383 and 384:
Fernandez, I., O-115 Fernandez, P.,
- Page 385 and 386:
Ismail, A. M., P-235, P-400, P-415
- Page 387 and 388:
Lo, K., O-153 Lonczak, A., O-56 Lon
- Page 389 and 390:
Palmor, M., P-161 Palomaki, G. E.,
- Page 391 and 392:
Sharma, P. A., P-359 Sharma, R., O-
- Page 393 and 394:
Wesselink, A., O-195 Wessels, C. E.
- Page 395 and 396:
P-404, P-405, P-408, P-409, P-411,
- Page 397 and 398:
Berro, R. Berwald, T. Bjugstad, K.
- Page 399 and 400:
Feinberg, R. F. Fields, R. A. Foida
- Page 401 and 402:
Leone Roberti Maggiore, U. DEKA, Sp
- Page 403 and 404:
Ready, K. Counsyl, Full-time compan
- Page 405:
Wells, D. Reprogenetics UK, Direct